Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. - Wikidata - awgldk - TriplyDB

Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.

Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.

http://www.wikidata.org/entity/Q34425497

about

Paget's disease of bone: an osteoimmunological disorder?Prevention and treatment of bone changes associated with exposure to glucocorticoids High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage Serum Sclerostin Levels in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis A review of osteocyte function and the emerging importance of sclerostin Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study.Bone mass in axial spondyloarthritis: A literature review.Involvement of Notch1/Hes signaling pathway in ankylosing spondylitis.Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis.Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL.Alterations of bone mineral density, bone microarchitecture and strength in patients with ankylosing spondylitis: a cross-sectional study using high-resolution peripheral quantitative computerized tomography and finite element analysis.Serum DKK-1 level in the development of ankylosing spondylitis and rheumatic arthritis: a meta-analysis.Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors.Osteoporosis and osteoarthritis, rheumatoid arthritis and spondylarthropathies.Wnt signaling in ankylosing spondylitis.EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.The ongoing quest for biomarkers in Ankylosing Spondylitis.Pathogenesis of ligaments ossification in spondyloarthritis: insights and doubts.Spinal fractures in patients with ankylosing spondylitis.Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.Lessons to be learned from serum biomarkers in psoriasis and IBD - the potential role in SpA.Assessment of bone metabolism and biomechanical properties of the femur, following treatment with anastrozole and letrozole in an experimental model of menopause.Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.Allicin attenuates inflammation and suppresses HLA-B27 protein expression in ankylosing spondylitis mice.An update on biomarker discovery and use in axial spondyloarthritis.Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis.Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis.

P2860

Q26796458-7388FDD9-0759-4B6B-B9BB-FC119F133CC9 Q26861474-1A081A5B-9F65-465E-86B6-A365BB48467C Q31113598-077AC2C2-A286-4D9E-B0EA-A8C75EA1F1B2 Q33695718-AC7DD0D2-65AA-4F91-9DD5-A69AE1BC2CEF Q34264395-0F4BA66E-9667-4B61-8D2A-5A6AC9AC7D82 Q34457833-862FAD86-946C-4BA5-A13A-99CC75ADB5AA Q35188767-EA0392CC-A5A5-4628-9DFD-313832CD4DB8 Q35632152-385401F9-AF4B-4F28-97E1-FC70F5219DB4 Q35809286-CCC00C2A-3A5E-41D8-A5AD-11A8AD63A0ED Q35870458-02116C6C-3610-435E-8B1C-83254249A1D1 Q36268235-464BB2F4-8607-429F-A847-2A487ED5B80B Q36477404-DFBBFC21-486E-4D2A-A755-C24BED7F4B10 Q36865107-17C50405-F9B5-472C-95AD-663E7C70046F Q37609095-B81CA5C2-31EF-45E9-BD0C-A8216A7A9EF1 Q38148506-D19CD5D7-F9FC-4DFB-9A68-E2EDB37090D9 Q38211262-DFB50396-BF8E-4616-AF25-E8A448DCDE79 Q38402703-2FF1B397-7A9C-4297-AC26-BB5F4FBA05B6 Q38607774-BCB1EA2A-9A2E-4A9C-8BBD-5026E431EACD Q38816459-2F86FDC9-120E-4563-984B-CAD3A2C968DD Q38886495-68FE9CC4-5019-4F6F-95AE-6A8B020D6882 Q38911778-910826DE-A6E1-4088-BA07-0846C34F66DC Q38972679-2F44955F-C8B3-480B-BBD1-F30F09888883 Q41388200-EBA3510E-8EC5-482A-92F1-0C970E45F55E Q41690873-43FA1EDE-F5BA-45DB-9564-2A8D0CBA962C Q42041341-7B436FF1-858E-415F-98DA-AD5BB10D7AFF Q47787817-6DDD0619-06BF-4541-8D14-64EE706BD523 Q51028700-7607C330-69B1-4623-9B7E-AABC761F7DBE Q53089538-1F36D8E0-507A-4976-A255-B159A1192949

P2860

Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.

http://www.wikidata.org/entity/Q34425497

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Biomarkers and cytokines of bo ...... s with ankylosing spondylitis.

@ast

Biomarkers and cytokines of bo ...... s with ankylosing spondylitis.

@en

Biomarkers and cytokines of bo ...... s with ankylosing spondylitis.

@nl

type

label

Biomarkers and cytokines of bo ...... s with ankylosing spondylitis.

@ast

Biomarkers and cytokines of bo ...... s with ankylosing spondylitis.

@en

Biomarkers and cytokines of bo ...... s with ankylosing spondylitis.

@nl

prefLabel

Biomarkers and cytokines of bo ...... s with ankylosing spondylitis.

@ast

Biomarkers and cytokines of bo ...... s with ankylosing spondylitis.

@en

Biomarkers and cytokines of bo ...... s with ankylosing spondylitis.

@nl

P1433

Q34425497-1201904F-B5D2-4F85-8332-5875AA809FB7

P1476

Q34425497-6F90448C-2325-4A95-AF77-B91AD224FBF1

P2093

Q34425497-225083F5-D3A3-4CFE-BC69-41760EBBF14E

Q34425497-2A10BB4B-9009-484F-9855-0621BE432B49

Q34425497-34BBF6CA-3E7F-4109-8EE7-26A660B7A0E1

Q34425497-3C6F9A2B-FE87-437C-B3BB-9E65073E5A5D

Q34425497-43C30E46-7695-43D5-93A4-D432C3722992

Q34425497-46F8F131-AF58-44BA-8AF3-6514580AD61A

Q34425497-B2BA95FF-99F7-4C92-B08B-CD2F4C04064C

Q34425497-C8311285-011E-4175-9D52-5A2E02CF41DE

Q34425497-CC88E7AE-1E4B-44DE-B035-54E33BF9E6EF

Q34425497-FD2E6E27-C5ED-4A64-B95A-0005EE85D56C

P2860

Q34425497-058F8BED-3BF2-4FF1-BA6D-82D50993F3C5

Q34425497-1EA03971-9C2A-4055-A28B-7C81943E85F2

Q34425497-3DD297B0-1408-404C-AC12-BADF3B9B9293

Q34425497-566653D2-E18C-42A1-BA96-F5305ACE8812

Q34425497-665DC5E3-AE67-4E08-9163-38DC3EF1613C

Q34425497-6E6BD85E-8F9C-4911-B909-C814B065D80C

Q34425497-734AFD06-B27B-4417-96DB-C44C7E0E8754

Q34425497-7DF8E57E-BBC7-4933-B84C-99970E7A3F6F

Q34425497-7F0B8E0F-A2F7-4B9F-8E64-E079453E98E0

Q34425497-86E9F51B-BF2B-4A9E-86EC-FE801E7548F9

P2888

Q34425497-45556728-7F3F-40B1-B5CB-C71259931B23

P304

Q34425497-ECC4D28B-D5CA-42C2-8AF3-82EFD83EE876

P31

Q34425497-C71D0574-1FEE-4486-9444-C55B9AD7C096

P356

Q34425497-E4FE17EE-EE5C-4A7B-8B23-FAE4F0848866

P478

Q34425497-D6E3574D-77F4-462E-86D8-78B7B7579F80

P577

Q34425497-8FA42348-D8F0-4C25-BFC8-23A819D4D031

P5875

Q34425497-73D8B341-046D-4630-A691-5F20640200D0

P6179

Q34425497-55D079DE-1676-487B-B04D-2EE6E684F6C8

P698

Q34425497-372C610B-E7D0-469A-93D6-22675301FB65

P921

Q34425497-33BF65A3-66E9-43AF-AA61-D7DB811F1BC0

P932

Q34425497-A6F96FD7-D8F9-4AF2-8DF7-04602A92CC75

P356

1471-2474-13-191

P1433

BMC Musculoskeletal Disorders

P1476

Biomarkers and cytokines of bo ...... s with ankylosing spondylitis.

@en

P2093

Ali Taylan

http://www.w3.org/2001/XMLSchema#string

Ayfer Colak

http://www.w3.org/2001/XMLSchema#string

Baris Akinci

http://www.w3.org/2001/XMLSchema#string

Didem Kozaci

http://www.w3.org/2001/XMLSchema#string

Hulya Yalcin

http://www.w3.org/2001/XMLSchema#string

Ismail Sari

http://www.w3.org/2001/XMLSchema#string

Necati Gunay

http://www.w3.org/2001/XMLSchema#string

Nurullah Akkoc

http://www.w3.org/2001/XMLSchema#string

Safak Bilge

http://www.w3.org/2001/XMLSchema#string

Servet Akar

http://www.w3.org/2001/XMLSchema#string

P2860

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Joint remodelling in inflammatory disease.

Osteoimmunology in rheumatic diseases

The role of Wnt proteins in arthritis.

Bone formation versus bone resorption in ankylosing spondylitis.

Bone remodeling in rheumatic disease: a question of balance.

Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future.

P2888

1471-2474-13-191

P304

191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2474-13-191

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231740220

http://www.w3.org/2001/XMLSchema#string

P6179

1005724730

http://www.w3.org/2001/XMLSchema#string

P698

23025387

http://www.w3.org/2001/XMLSchema#string

P921

P932

3492209

http://www.w3.org/2001/XMLSchema#string